The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106503222 10650322 2 F 20140401 20160921 20141213 20160927 EXP IT-MINISAL02-281714 IT-MYLANLABS-2014M1012845 MYLAN 0.00 Y 0.00000 20160927 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106503222 10650322 1 PS ITRACONAZOLE. ITRACONAZOLE 1 Oral 100 MG, QD Y 200463 100 MG QD
106503222 10650322 2 SS PRADAXA DABIGATRAN ETEXILATE MESYLATE 1 Oral 220 MG, QD 11880 MG Y 0 220 MG CAPSULE, HARD QD
106503222 10650322 3 C LASIX FUROSEMIDE 1 Oral 50 MG, UNK D 0 50 MG TABLET
106503222 10650322 4 C KANRENOL CANRENOATE POTASSIUM 1 Oral 25 MG, UNK D 0 25 MG TABLET
106503222 10650322 5 C PANTORC PANTOPRAZOLE SODIUM 1 Oral 40 MG, UNK D 0 40 MG GASTRO-RESISTANT TABLET
106503222 10650322 6 C SIMVASTATIN. SIMVASTATIN 1 Oral 20 MG, UNK D 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106503222 10650322 1 Onychomycosis
106503222 10650322 2 Atrial fibrillation
106503222 10650322 3 Product used for unknown indication
106503222 10650322 4 Product used for unknown indication
106503222 10650322 5 Product used for unknown indication
106503222 10650322 6 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
106503222 10650322 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106503222 10650322 Muscle haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106503222 10650322 1 20140401 20140506 0
106503222 10650322 2 20140207 20140727 0